Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIVNewsfile Corp. - News Releases • 29 days ago
Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the...
Share to Feed
Acurx Pharmaceuticals (NASDAQ:ACXP Get Free Report) had its price objective reduced by equities researchers at HC Wainwright from $14.00 to $12.00 in a report issued on Tuesday, Benzinga...
Acurx Pharmaceuticals (NASDAQ:ACXP Get Free Report) had its price target decreased by stock analysts at HC Wainwright from $14.00 to $12.00 in a research report issued on Tuesday, Benzinga...
Related Stocks: NAS:ACXP...
Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers...
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides...
Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update Acurx Pharmaceuticals, Inc. to Discuss Fourth...
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development Acurx...
"New to The Street Leadership" Broadcast on Bloomberg TV as Sponsored Programming on Saturday, February 24, 2024, at 6:30 PM ET, and the "New to The Street" Business Broadcast on the FOX Business...